Navigation Links
ISTA Pharmaceuticals Files New Drug Application with U.S. FDA for Bepreve(TM)
Date:11/13/2008

IRVINE, Calif., Nov. 13 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced the Company filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for Bepreve(TM) (bepotastine ophthalmic solution). The Company is seeking approval for Bepreve as an eye drop treatment for ocular itching associated with allergic conjunctivitis.

ISTA filed the Bepreve NDA electronically, in eCTD format and using the FDA's Electronic Submission Gateway. Pending FDA validation of the electronic file in the coming days and timely acceptance of the filing by the FDA, ISTA expects a standard review of ten months from date of receipt.

In April of this year, ISTA announced highly statistically significant reductions in the primary study endpoint of ocular itching from the preliminary analysis of its second and final Bepreve Phase III clinical study. In addition, the results showed Bepreve had a statistically significant effect on the rapidity of response and in certain secondary endpoints measuring additional signs or symptoms of ocular allergy, including improvement in nasal symptoms. There were no serious ocular adverse events reported in patients dosed with Bepreve from the study.

About Bepreve(TM) (bepotastine ophthalmic solution)

Assuming both timely acceptance by the FDA of the Bepreve NDA for filing and approval to market, Bepreve would participate in the U.S. ocular allergy market, which had estimated 2007 sales of approximately $560 million based on data from IMS Health. Assuming approval, Bepreve would participate in ISTA's largest market to date, as compared to ISTA's currently marketed products.

Bepreve has three primary mechanisms of action: it is a non-sedating
'/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Memory Pharmaceuticals Reports Third Quarter 2008 Financial Results
2. Chemical Engineering Conference Highlights Energy, Biomedicine, Pharmaceuticals, Sustainability and Centennial
3. Potentia Pharmaceuticals Appoints Johanna M. Seddon, M.D. and Janet Stoltz Sunness, M.D. to Scientific Advisory Board
4. Nventa Biopharmaceuticals Announces Third Quarter 2008 Financial Results and Recent Corporate Highlights
5. Amylin Pharmaceuticals Announces Strategic Restructuring and Workforce Reduction
6. Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2008 Results
7. Potentia Pharmaceuticals Drug Candidate for Age-Related Macular Degeneration Shows Positive Safety Profile in Phase I Clinical Trial
8. Transdel Pharmaceuticals, Inc. Retains The Investor Relations Group
9. Idenix Pharmaceuticals to Present at Deutsche Banks 2008 Biotech Boston Confab
10. Critical Pharmaceuticals Raise GBP650K
11. Onyx Pharmaceuticals Licenses Rights to Novel Targeted Oncology Agent From BTG International
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Miami, FL (PRWEB) June 19, 2013 An ... shed light on the increasing number of uses for probiotics. ... have probiotic qualities, and the associate benefits may beeb listed, ... health, reducing inflammation, and helping clear skin conditions. While the ... News shed light on the the uses of these “miracle” ...
(Date:6/19/2013)... June 19, 2013 ... announced the addition of the "Global ... report to their offering. ... of data protection and old security practises ... have driven the growth of biometric technologies ...
(Date:6/19/2013)... ROCKVILLE, Md. , June 19, 2013 Synthetic ... on the prevention and treatment of serious infectious diseases, announced ... the 6 th Annual OneMedForum New York Conference on ... New York City . Mr. Riley is scheduled ... live webcast of Synthetic Biologics, presentation can be accessed by ...
(Date:6/19/2013)... BREA, Calif. , June 19, 2013  Continuing ... of myocardial infarction (MI), Beckman Coulter , Inc. ... clearance of its new Access AccuTnI+3 troponin I assay ... "Clinicians have depended on Beckman Coulter,s ... the new AccuTnI+3 assay has the proven performance to ...
Breaking Biology Technology:Natural Acne Remedy, Probiotic Action Explains the Science behind Using Probiotics for Better Health 2Global Biometric Systems Market Forecast Report - Opportunities to 2018 2Global Biometric Systems Market Forecast Report - Opportunities to 2018 3Synthetic Biologics to Present at OneMedForum New York 2013 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3
... three months until DEMO 2006, the screening and selection process ... A bit more than one-third of the class has been ... more applications to bring the total number of new products ... point in the process, I begin to get a sense ...
... Inc., a global provider of enterprise information quality solutions, ... document management solutions company based in Connecticut, have verbally ... expires November 15, concluding Pitney's planned acquisition of Firstlogic. ... 1. After a review of a Second Request for ...
... banging the drum for business alignment for several years now. ... dancing in and out of conference rooms across America? , ... the emergence of the hybrid CIO. One of the most ... a part of the business unrelated to IT. I have ...
Cached Biology Technology:DEMO 2006: A sea change is coming 2DEMO 2006: A sea change is coming 3Now comes the hybrid CIO 2Now comes the hybrid CIO 3
(Date:6/18/2013)... are expecting a very large "dead zone" in the ... level in the Chesapeake Bay this year, based on ... University of Michigan, Louisiana State University, and the ... Gulf of Mexico hypoxic "dead" zone will be between ... among the ten largest recorded. That would range from ...
(Date:6/18/2013)... Bethesda, MD, June 18, 2013: The Association for Molecular ... Federation of American Societies for Experimental Biology (FASEB) on ... for membership on June 3, 2013. , The ... individuals and share a common vision for the advancement ... "Basic biomedical and translational research is more important now ...
(Date:6/18/2013)... team of internationally recognized feline experts including veterinarians and ... University of Lincoln, U.K. and Dr Ilona Rodan, Director ... the International Society of Feline Medicine (ISFM) and the ... for veterinarians, owners and those working with cats on ... cat. The new guidelines appear in the Journal ...
Breaking Biology News(10 mins):NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 3NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 4Feline behavior experts release guidelines to improve the welfare of cats 2
... Two new studies present evidence that the virus causing severe ... just through direct contact with contaminated water droplets as previous ... air in a patient's room during the 2003 outbreak in ... of Infectious Diseases. Another study, from Hong Kong, shows patients ...
... paleontologists states that when dinosaurs died and became ... essentially transformed into "rocks" through a gradual replacement ... by a North Carolina State University paleontologist, however, ... Dr. Mary Schweitzer, assistant professor of paleontology with ...
... harness the energy of ATP (or GTP, a related ... examples of motors include myosin and dynein, proteins that ... of actin or tubulin proteins. The ATP-dependent assembly of ... motor: for instance, the march of white blood cells ...
Cached Biology News:New studies suggest airborne SARS transmission is possible 2NC State scientist finds soft tissue in T. rex bones 2DNA Recombination and Repair—A New Twist to RecA Function 2
... 96-well semi-skirted PCR plate, Directly compatible ... sequencers, Flat deck for improved sealing characteristics ... adhesive seals, mats or cap strips, Certified ... DNA We are part of Thermo Fisher ...
Vented Caps for 75 cm2 Flasks...
BD Falcon Center-well 60 mm In Vitro Fertilization (IVF) Dish, nonembryotoxic, noncytotoxic, tissue-culture treated polystyrene. (20/sp, 500/ca) Packaging: 20 / sleeve, 500 / case ...
Gelatin 100 mm Culture Dishes...
Biology Products: